MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer
出版年份 2021 全文链接
标题
MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer
作者
关键词
-
出版物
MOLECULAR PHARMACEUTICS
Volume 18, Issue 8, Pages 3010-3025
出版商
American Chemical Society (ACS)
发表日期
2021-06-28
DOI
10.1021/acs.molpharmaceut.1c00213
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of Hypoxia on Proliferation and the Expression of the Genes HIF-1α and JMJD1A in Head and Neck Squamous Cell Carcinoma Cell Lines
- (2021) CHRISTIAN WILHELM et al. ANTICANCER RESEARCH
- MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human Breast Cancer
- (2021) Yu Li et al. PATHOLOGY RESEARCH AND PRACTICE
- Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
- (2020) József Dudás et al. Cells
- Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
- (2020) Prathibha Kirave et al. Oncotarget
- Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2
- (2020) Bhagyashri Kulkarni et al. Oncotarget
- 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment
- (2020) Linas Kunigenas et al. Biomolecules
- The role of epithelial-mesenchymal transition in regulating radioresistance
- (2020) Suna Zhou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Modeling neoplastic disease with spheroids and organoids
- (2020) Michele Zanoni et al. Journal of Hematology & Oncology
- Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer
- (2020) Yaqing Li et al. Molecular Cancer
- Downregulated FOXO3a Associates With Poor Prognosis and Promotes Cell Invasion and Migration via WNT/β-catenin Signaling in Cervical Carcinoma
- (2020) Yuejun Tian et al. Frontiers in Oncology
- Hypoxia-mediated cancer stem cell resistance and targeted therapy
- (2020) Xiaoyu Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytokine profiling in serum-derived exosomes isolated by different methods
- (2020) Hae Hyun Jung et al. Scientific Reports
- Correction: miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells
- (2019) Piyush Gondaliya et al. PLoS One
- Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2
- (2019) Jun Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research
- (2019) Ziba Nariman-Saleh-Fam et al. Biomarkers in Medicine
- Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
- (2019) Hyeong Sim Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reactive Oxygen Species in the Tumor Microenvironment: An Overview
- (2019) Frank Weinberg et al. Cancers
- MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a
- (2019) Xiaoting Li et al. Cancer Biomarkers
- Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
- (2019) Zixian Huang et al. Cell Death & Disease
- FOXO3a Reverses the Cisplatin Resistance in Ovarian Cancer
- (2018) Mudan Lu et al. ARCHIVES OF MEDICAL RESEARCH
- Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT
- (2018) Tulika Mitra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer
- (2018) Xinyi Wang et al. MOLECULAR THERAPY
- The role of HIF-1α in chemo-/radioresistant tumors
- (2018) Yu Xia et al. OncoTargets and Therapy
- MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
- (2018) Yuewen Gao et al. Oncology Letters
- LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway
- (2018) Peng Wang et al. APOPTOSIS
- Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo
- (2018) Zahra Naseri et al. International Journal of Nanomedicine
- MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
- (2018) Xin Chen et al. Oncology Letters
- Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation
- (2017) Fang-Wei Hu et al. Oncotarget
- Oral cancer: A multicenter study
- (2017) K Dhanuthai et al. Medicina Oral Patologia Oral y Cirugia Bucal
- An Efficient and Flexible Cell Aggregation Method for 3D Spheroid Production
- (2017) Sarah M. Maritan et al. Jove-Journal of Visualized Experiments
- Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis
- (2017) Lingling Bai et al. Scientific Reports
- Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells
- (2016) Surya P. Lamichhane et al. BMC CANCER
- Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
- (2016) Katrien Van Roosbroeck et al. CLINICAL CANCER RESEARCH
- Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2
- (2016) QI ZENG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
- (2016) Xuesong Chen et al. Scientific Reports
- MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features
- (2016) Ruma Dey Ghosh et al. Scientific Reports
- FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
- (2015) Hao Liu et al. CELLULAR SIGNALLING
- Hypoxia and free radicals: Role in tumor progression and the use of engineering-based platforms to address these relationships
- (2015) Abigail Hielscher et al. FREE RADICAL BIOLOGY AND MEDICINE
- Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells
- (2014) YOSHIHIRO NAKAGAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics
- (2014) Mayakannan Manikandan et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- miRNA profiling of cancer
- (2013) Gianpiero Di Leva et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
- (2013) L Chang et al. Cell Death & Disease
- The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases
- (2013) Bo Wang et al. Chinese Journal of Cancer
- Rapid aggregation of heterogeneous cells and multiple-sized microspheres in methylcellulose medium
- (2012) Nobuhiko Kojima et al. BIOMATERIALS
- Enhanced cisplatin resistance in oral-cancer stem-like cells is correlated with upregulation of excision-repair cross-complementation group 1
- (2012) Lo-Lin Tsai et al. Journal of Dental Sciences
- Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model
- (2012) N. Arya et al. Journal of the Royal Society Interface
- Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
- (2012) Shin-ichiro Ohno et al. MOLECULAR THERAPY
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells
- (2011) Imran A. Babar et al. CANCER BIOLOGY & THERAPY
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy
- (2011) Viktoriya Sokolova et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypoxia-inducible factor-1α mediates oral squamous cell carcinoma invasion via upregulation of α5 integrin and fibronectin
- (2010) Mi Heon Ryu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box-Binding Protein 1, and E-Cadherin Regulation
- (2010) M. Shiota et al. CLINICAL CANCER RESEARCH
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
- (2009) Min Fei et al. CANCER INVESTIGATION
- Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration
- (2009) Zhang Lei et al. PLoS One
- Reactive oxygen species in tumor metastasis
- (2008) Makiya Nishikawa CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started